Pasquale Assennato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pasquale Assennato has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Salvatore Novo
Division of Cardiology, Biomedical Department of Internal Medicine and Specialties (DiBiMIS), Paolo Giaccone Hospital, University of Palermo, Palermo, Italy
40 shared publications - Giuseppina Novo
Division of Cardiology, University Hospital Paolo Giaccone, 90127 Palermo, Italy
28 shared publications - Giuseppe Coppola
Unità Operativa Semplice Terapia Intensiva Cardiologica, Azienda Ospedaliero-Universitaria Policlinico Paolo Giaccone, 90127 Palermo, Italy
22 shared publications Antonino Rotolo
14 shared publications- Egle Corrado
O.U. of Cardiology University Hospital P. Giaccone Palermo Italy
14 shared publications - Giovanni Fazio
Department of Cardiology, University of Palermo, Italy
10 shared publications
Latest Publications
- 1 October 2017
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 18 (10) , 815-817
A strange pneumonia
- 1 October 2017
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 18 (10) , 815-817
A strange pneumonia
- 1 October 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 197, 78-80
Coronary artery fistulas and Brugada ECG pattern, a random association?
- 1 October 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 197, 78-80
Coronary artery fistulas and Brugada ECG pattern, a random association?
- 1 October 2015
- Published by Czech Society of Cardiology in Cor et Vasa
- Vol. 57 (5) , e334-e340
Coronary artery perforation: How to treat it?
Coronary artery perforation fortunately represents a rare complication of coronary catheterization but, if not properly and promptly treated, it is burdened by a high mortality rate. Rates of coronary perforation may be potentially higher when atherectomy devices are used or very complex calcified lesions are treated. Cardiac tamponade constitutes the most severe clinical consequence.We report the case of an intra-stent coronary perforation at the end of revascularization of a non-ST elevation myocardial infarction (NSTEMI), followed by an immediate impairment of hemodynamic compensation, due to significant pericardial effusion and subsequent cardiac tamponade.The use of covered stents has revolutionized the management of coronary perforation and this has meant that the use of emergency CABG has decreased over the years with satisfactory immediate and short-term outcomes, reducing the incidence of acute cardiac tamponade and mortality without surgery
- 1 October 2015
- Published by Czech Society of Cardiology in Cor et Vasa
- Vol. 57 (5) , e334-e340
Coronary artery perforation: How to treat it?
Coronary artery perforation fortunately represents a rare complication of coronary catheterization but, if not properly and promptly treated, it is burdened by a high mortality rate. Rates of coronary perforation may be potentially higher when atherectomy devices are used or very complex calcified lesions are treated. Cardiac tamponade constitutes the most severe clinical consequence.We report the case of an intra-stent coronary perforation at the end of revascularization of a non-ST elevation myocardial infarction (NSTEMI), followed by an immediate impairment of hemodynamic compensation, due to significant pericardial effusion and subsequent cardiac tamponade.The use of covered stents has revolutionized the management of coronary perforation and this has meant that the use of emergency CABG has decreased over the years with satisfactory immediate and short-term outcomes, reducing the incidence of acute cardiac tamponade and mortality without surgery
- 14 September 2015
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 87 (7) , 1258-1268
STEMI patients and nonculprit lesions: To treat or not to treat? and when? A review of most recent literature
Patients with ST segment elevation myocardial infarction and multivessel disease represent a high percentage of ischemic patient with a worse outcome than patient with single coronary artery disease. Therefore, initial management of these patients is of high importance, but unfortunately this is not clarified yet. We analyze the available literature trying to afford current doubts to determine which way of revascularization is to be preferred.
- 14 September 2015
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 87 (7) , 1258-1268
STEMI patients and nonculprit lesions: To treat or not to treat? and when? A review of most recent literature
Patients with ST segment elevation myocardial infarction and multivessel disease represent a high percentage of ischemic patient with a worse outcome than patient with single coronary artery disease. Therefore, initial management of these patients is of high importance, but unfortunately this is not clarified yet. We analyze the available literature trying to afford current doubts to determine which way of revascularization is to be preferred.
- 1 September 2015
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 16 (9) , 639-643
G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy
Takotsubo cardiomyopathy (TTC) is an increasingly reported clinical syndrome that mimics acute myocardial infarction without obstructive coronary artery disease and is characterized by transient systolic dysfunction of the apical and/or mid-segments of the left ventricle. The syndrome mainly occurs in postmenopausal women with high adrenergic state conditions. Nowadays, the pathophysiology of TTC is not yet known and the possibility of a genetic predisposition is controversial. The purpose of this study was to assess the genetic susceptibility to TTC through analysis of the L41Q polymorphism of the G-protein-coupled receptor kinase 5 (GRK5). In a cohort of 20 patients enrolled in two tertiary Italian centers with diagnosis of TTC, accordingly to the commonly accepted Mayo Clinic criteria and in 22 healthy individuals (control) we have evaluated the polymorphism in GRK5 gene. The TTC patients had a mean age of 65 ± 9 years and 19 of 20 were women. The presence of one or two L41 alleles of GRK5 was significantly more frequent in TTC group than in the control group (40 vs. 8%, P = 0.0372). In our study, we have found a significant difference in the frequency of GRK5 polymorphism between TTC patients and controls, supporting a genetic predisposition to this cardiac syndrome.
- 1 September 2015
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 16 (9) , 639-643
G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy
Takotsubo cardiomyopathy (TTC) is an increasingly reported clinical syndrome that mimics acute myocardial infarction without obstructive coronary artery disease and is characterized by transient systolic dysfunction of the apical and/or mid-segments of the left ventricle. The syndrome mainly occurs in postmenopausal women with high adrenergic state conditions. Nowadays, the pathophysiology of TTC is not yet known and the possibility of a genetic predisposition is controversial. The purpose of this study was to assess the genetic susceptibility to TTC through analysis of the L41Q polymorphism of the G-protein-coupled receptor kinase 5 (GRK5). In a cohort of 20 patients enrolled in two tertiary Italian centers with diagnosis of TTC, accordingly to the commonly accepted Mayo Clinic criteria and in 22 healthy individuals (control) we have evaluated the polymorphism in GRK5 gene. The TTC patients had a mean age of 65 ± 9 years and 19 of 20 were women. The presence of one or two L41 alleles of GRK5 was significantly more frequent in TTC group than in the control group (40 vs. 8%, P = 0.0372). In our study, we have found a significant difference in the frequency of GRK5 polymorphism between TTC patients and controls, supporting a genetic predisposition to this cardiac syndrome.
- 1 July 2015
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 16 (5) , 306-309
Coronary artery fistulas as a cause of angina: How to manage these patients?
- 1 July 2015
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 16 (5) , 306-309
Coronary artery fistulas as a cause of angina: How to manage these patients?
- 1 February 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 180, 255-257
Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction
- 1 February 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 180, 255-257
Troponin I/ejection fraction ratio: A new index to differentiate Takotsubo cardiomyopathy from myocardial infarction
- 1 January 2015
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 26 (1) , 91-93
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent
- 1 January 2015
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 26 (1) , 91-93
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent
- 1 December 2014
- Vol. 62 (6) , 497-9
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
- 1 December 2014
- Vol. 62 (6) , 497-9
Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
- 1 October 2014
- Vol. 62 (5) , 369-78
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Arrhythmogenic right ventrticular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy characterized by fibrofatty replacement and a high risk of ventricular arrhythmias (VA) and sudden cardiac death (SCD). The aim of the present investigation is to examine the pathological profile and the clinical correlations in a group of ARVD/C patients. We conducted a multicenter study evaluating 47 patients (31 men; mean age 37±14 years) with definite ARVD/C. Diagnosis was established according to the actual clinicomorphologic criteria at autopsy or clinically. We divided the study population in 2 different groups. First group included 28 alive patients and the second 19 patients dead suddenly. Age at presentation was different in the two groups (P=0.0015). We observed an important association regarding the risk of sudden death and the history of physical exercise (P=0.0017). Moreover patients with negative outcome (i.e., SCD, cardiac transplantation, congestive heart failure) had a significantly association with biventricular form of ARVD/C (P=0.0034) and age presentation (P=0.003). Left ventricular (LV) involvement was frequently observed in the two groups (17% and 32% respectively). Post-mortem examination revealed frequent inflammatory infiltrates (26%) indicating active myocarditis, which probably justify the fatal arrhythmic events occurred in these patients. Frequent LV involvement justifies the recent adoption of the broad term Arrhythmogenic Cardiomyopathy. Early age presentation, sport activity and the biventricular form of ARVD/C represent important predictors of adverse outcome that can be useful to early identify patients at high risk.
- 1 October 2014
- Vol. 62 (5) , 369-78
Anatomical features and clinical correlations in Caucasian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Arrhythmogenic right ventrticular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy characterized by fibrofatty replacement and a high risk of ventricular arrhythmias (VA) and sudden cardiac death (SCD). The aim of the present investigation is to examine the pathological profile and the clinical correlations in a group of ARVD/C patients. We conducted a multicenter study evaluating 47 patients (31 men; mean age 37±14 years) with definite ARVD/C. Diagnosis was established according to the actual clinicomorphologic criteria at autopsy or clinically. We divided the study population in 2 different groups. First group included 28 alive patients and the second 19 patients dead suddenly. Age at presentation was different in the two groups (P=0.0015). We observed an important association regarding the risk of sudden death and the history of physical exercise (P=0.0017). Moreover patients with negative outcome (i.e., SCD, cardiac transplantation, congestive heart failure) had a significantly association with biventricular form of ARVD/C (P=0.0034) and age presentation (P=0.003). Left ventricular (LV) involvement was frequently observed in the two groups (17% and 32% respectively). Post-mortem examination revealed frequent inflammatory infiltrates (26%) indicating active myocarditis, which probably justify the fatal arrhythmic events occurred in these patients. Frequent LV involvement justifies the recent adoption of the broad term Arrhythmogenic Cardiomyopathy. Early age presentation, sport activity and the biventricular form of ARVD/C represent important predictors of adverse outcome that can be useful to early identify patients at high risk.